Psoriatic arthritis (PsA) patients who also qualified for a diagnosis of metabolic syndrome were far more likely to meet criteria for a difficult-to-treat (D2T) form of their rheu ...

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...

Two studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate, but ...

EULAR - The European Alliance of Associations for Rheumatology - recommends a treat-to-target approach, and suggests more ...

About one-third of psoriasis sufferers develop psoriatic arthritis, with swelling, tenderness and pain in joints, affecting daily activities and lifestyle. Psoriatic arthritis (PsA) is a chronic ...

Modifiable lifestyle factors significantly affect the incidence of psoriatic disease, cardiometabolic comorbidities, and all-cause mortality.

The following is a summary of “Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal ...

Enthesitis is a key, but often overlooked, feature of psoriatic arthritis. Learn how this inflammation at tendon and ligament attachment sites can affect diagnosis, symptoms, and treatment.